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Background & Aims: The risk of developing colorectal neoplasia is not well established 
among family members of individuals with large adenomas and screening strategies remain 
under debate in this population. This study aimed at quantifying the risk of colorectal 
adenomas and cancers using colonoscopic screening in first-degree relatives of patients with 
large adenomas. 
Methods: This case-control study was performed in 18 endoscopic units of French non-
University Hospitals. A colonoscopy was offered to first-degree relatives of 306 index cases 
with adenomas ≥ 10 mm, if they were alive, aged 40-75 and could be contacted by the index 
case. Among 674 relatives meeting these criteria, 168 were examined and matched for age, 
gender, and geographical area with two controls (n=307). Controls were randomly selected 
from 1362 consecutive patients aged 40-75 having undergone a colonoscopy for minor 
symptoms.  
Results: The overall prevalence of large adenomas was 8.4% and 4.2% in relatives and 
controls, respectively. Odds ratios (OR) associated with a history of large adenomas in 
relatives were 2.27 (95% confidence interval [CI]: 1.01-5.09) for cancers or large adenomas 
and 1.21 (95% CI: 0.68-2.15) for small adenomas, and 1.56 (95% CI: 0.96-2.53) for all 
colorectal neoplasia. The risk of large adenomas and cancers was higher in relatives of index 
cases younger than 60 years (OR: 3.82; 95% CI: 0.92-15.87) and when the index case had 
large distal adenomas (OR, 3.14; 95% CI: 1.27-7.73). 
Conclusion: First-degree relatives of patients with large adenomas are at increased risk of 
developing colorectal cancers or large adenomas. This result has implications for screening in 
this high-risk population. 
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Colorectal cancer is one of the most common cancers in developed countries, especially in 
France, where more than 36,000 new cases were diagnosed in 2000 
1
. Colorectal adenomas 
are known precursors of most cancers and have high malignancy potential when they are ≥ 
10mm diameter and/or present severe dysplasia and/or villous component 
2
. Therefore, 
detection and removal of colorectal adenomas are presently the best way to reduce cancer 
incidence and, subsequently, mortality from this cancer 
3, 4
. 
Apart from the two defined genetic syndromes, the Familial Adenomatous Polyposis 
syndrome and the Hereditary Non Polyposis Colorectal Cancer syndrome, familial clustering 
of sporadic colorectal cancer is now well recognized. In 2001, a systematic review of 27 
epidemiological studies showed that the risk of colorectal cancer increased by 2.25 (95% 
confidence interval [CI] from 2.00 to 2.53) in first-degree relatives of colorectal cancer cases 
5
. This finding was confirmed in a more recent meta-analysis of 59 studies, which found a 
relative risk of 2.24 associated with a history of colorectal cancer in first-degree relatives 
6
. 
The strength of association varied, in particular, according to the number of affected first-
degree relatives (from 1.85 for one relative to 8.52 for at least three affected relatives) and the 
age of relatives at diagnosis (from 2.18 for relatives ≥ 50 years to 3.55 for affected relatives < 
50 years). 
The adenoma-carcinoma sequence suggests that colorectal adenomas and cancers share 
common environmental and genetic risk factors. However, relatively few epidemiological 
studies have investigated the risk of developing colorectal neoplasia for first-degree relatives 
of patients with adenomas. A meta-analysis of nine studies estimated the relative risk of 
colorectal cancer in relatives of patients with adenomas as 1.99 (95% CI, 1.55-2.55) 
5
. Most 
of these studies used a similar design and compared the frequency of self-reported family 
history of colorectal cancer among patients with adenomas and either polyp-free controls, or 
spouse controls, or hospital controls. Thus, the choice of the control group may be 
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questionable in some of these studies. Furthermore, information on relatives was not obtained 
by colonoscopic screening but by interview and is possibly subject to recall biases in the 
reporting of family histories of colorectal cancers. In addition, these studies could not provide 
an estimation of the risk of colorectal adenomas, especially high-risk adenomas, in relatives 
of patients with adenomas. In this targeted population, this latter point is important because 
the choice of the screening strategy largely depends on the magnitude of the risk of both 
colorectal adenomas and cancers. As a consequence, screening procedures for relatives of 
patients with high-risk adenomas are not as well-established as screening strategies for 
relatives of patients with colorectal cancer.  
The GEADE study, a French study about the genetic factors of colorectal adenomas, gave 
us the opportunity to use an original design to compare the prevalence of colorectal neoplasia 
detected by endoscopy in first-degree relatives of patients with large adenomas, and in 
matched endoscopic control patients. Following the findings of a previous work among first-
degree relatives of patients with colorectal cancer 
7
, the aim of the present study was to 
demonstrate and quantify the high risk of both cancers and large adenomas, in first-degree 
relatives of patients with large adenomas. 
 
Methods 
Study subjects and data collection 
The GEADE study is a case-control and family study of patients with high-risk 
adenomas. The primary aim was to compare the frequency of various susceptibility genes in 
patients with large adenomas (index cases) and in controls with small adenomas or free of 
adenomas 
8
. A secondary aim based on the family part of the study was to assess the 
compliance with colonoscopy in first-degree relatives with large adenomas 
9
. 
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The study was performed in 18 participating gastroenterology units in French non-
university hospitals. They were located in small to medium-sized towns throughout the 
country (six towns were in a large area around Paris called ‘Greater Paris area’, three in north-
east France, two in the South-west, three in the South-east and four in central France). 
Subjects involved in the present analysis were first-degree relatives of patients with large 
colorectal adenomas. From September 1995 to March 2000, 306 consecutive patients with a 
newly- diagnosed adenoma ≥ 10mm were enrolled and referred as index cases. Index cases 
had no previous history of colorectal cancer or other cancer, familial adenomatous polyposis 
syndrome, established hereditary non-polyposis colorectal cancer and inflammatory bowel 
diseases. As indicated in Figure 1, 267 patients out of 306 consented to provide information 
on their family during a face-to-face interview with participating gastroenterologists. Family 
data included information on all first-degree relatives (parents, siblings and offspring), i.e. 
demographic and medical characteristics such as name, date of birth and/or age, residence 
area, vital status, cause and age at death if applicable, history of polyps or cancer. In 
accordance with French ethical rules, relatives of the patients were not directly contacted by 
the investigators. During a special consultation, the study was explained to the index cases 
who were asked to contact their relatives and to pass on an explanatory booklet. The booklet 
contained an explanatory letter describing the aims of the study and its implementation, 
general information about colorectal cancer, an informed consent sheet showing the 
advantages and potential drawbacks of colonoscopy and a health study questionnaire. 
Information about the genetic part of the study was given, together with a specific informed 
consent form, tubes for blood sampling and a letter for the customary laboratory used by the 
relative. Unless they had undergone a colonoscopy during the five preceding years, relatives 
aged 40-75 were asked to have a colonoscopy with the gastroenterologist of their choice 
including gastroenterologists practising outside study centres. 
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Among 1763 first-degree relatives identified, 674 were alive, aged 40-75 and could be 
contacted by the index case. One hundred and seventy relatives from 97 families underwent a 
colonoscopy. Among them, 56 relatives had been examined over the five preceding years, and 
114 underwent a screening colonoscopy resulting in an overall proportion of subjects with 
colonoscopy of 25% 
9
. Reports of endoscopic and, if applicable, histological examinations 
were obtained for all but 10 relatives, of which eight declared that no lesion was discovered 
during their colonoscopy and two did not know the results of the colonoscopy. These last two 
subjects were excluded from the present study. Thus, the case group was composed of 168 
first-degree relatives. The colonoscopy was complete in 134 first-degree relatives (79.8%), 
reached the ascending colon in two relatives, whereas no information about the level of 
colonoscopy was obtained for 32 relatives. 
Potential controls were extracted from 4133 consecutive patients aged 40-75 who had 
undergone a complete colonoscopy in one of the 18 gastroenterology units over a period of 
one year (or 6 months for 3 centres). Patients with a personal history of colorectal neoplasia 
(n=1072) or inflammatory bowel disease (n=104), established hereditary non-polyposis 
colorectal cancer or familial adenomatous polyposis (n=5), and who reported a family history 
of colorectal cancer and adenomas (n=696) were excluded, as well as those who had 
undergone a colonoscopy for the following indications: a positive faecal occult blood test 
(n=43), search for an occult primary tumour (n=98), rectal bleeding (n=505)or severe 
symptoms such as anaemia (n=155), digestive haemorrhage (n=33), bowel obstruction 
(n=28), or altered overall condition (n=32). These exclusion criteria aimed at avoiding any 
over-representation of patients with higher-than-average risk of neoplasia. Finally, 1362 
colonoscopic controls met the eligibility criteria. They presented the following indications: 
abdominal pain (40.0%), diarrhoea/constipation (24.7%), both abdominal pain and 
diarrhoea/constipation (20.0%) or miscellaneous indications (15.2%). Each first-degree 
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relative was matched for age, gender and geographical area with two control patients 
randomly selected from eligible controls. Because only one control could be found for 29 
relatives, the control group was composed of 307 patients. Major indications for colonoscopy 
in selected controls were abdominal pain (43.6%), diarrhoea/constipation (22.5%), both 
abdominal pain and diarrhoea/constipation (19.9%) or miscellaneous indications such as 
suspected diverticular disease (14.0%). 
For index cases, relatives and matched controls, lesion location was defined as distal 
(including rectum, rectosigmoïd, sigmoïd, descending colon and splenic flexure) and 
proximal (including transverse colon, hepatic flexure, ascending colon and caecum). 
The research protocol was approved by the ethics committee of Kremlin-Bicêtre 
Hospital. All index patients and first-degree relatives gave their signed informed consent. 
 
Statistical analysis 
The study design was based on the results of our previous work among first-degree 
relatives of patients with colorectal cancer
7
. A priori calculations of the sample size were as 
follows: assuming about 2.5 relatives per index case who would be contacted and a 
participation rate of 30% among relatives, the recruitment of 252 index cases provided a 
statistical power of 80% to detect an odds ratio (OR) of 2.5 associated with a high risk of both 
cancers and large adenomas, with 2 controls per case and a prevalence of cancers/large 
adenomas of 4% in controls (unilateral test). For added security, we extended the recruitment 
of index cases to 306. 
A logistic regression analysis was used to compare the prevalence of lesions between 
relatives and control subjects, and results were expressed as odds ratios (OR) and 95% CI. 
Both conditional and unconditional logistic regressions, adjusted for matching variables (age, 
geographical area and sex), were performed. Because they yielded very close results, we have 
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chosen to show results from the unconditional logistic regression only for sake of simplicity. 
In these analyses, the most severe colonoscopic finding was introduced as an independent 
variable in several ways. It was considered as a dichotomous variable (cancer or adenomas 
versus no colorectal neoplasia), a four-class categorical variable (cancer versus large 
adenomas versus small adenomas versus no colorectal neoplasia), or a three-class categorical 
variable (cancer or large adenomas versus small adenomas versus no colorectal neoplasia). In 
addition, stratified logistic regression analyses were carried out according to characteristics of 
the index case at diagnosis. Given that there may be some degree of correlation between 
relatives of the same family, main data were reanalyzed by keeping only one relative per 
family (n=96) and matched controls (n=174). The analysis included all relatives from families 
with a single member and one randomly selected relative from each family with 2 or more 
members. All statistical analyses were performed using SAS software (version 9.1; SAS 
Institute, Cary, North Carolina, USA). 
 
Results 
The median age of first-degree relatives and controls was 53 years and 57 years, 
respectively. Among the 168 first-degree relatives, there were 12 parents (7.1%) of the index 
case, 104 siblings (61.9%) and 52 children (31.0%). The median age was 66 years for the 
parents (range 52-74), 61 years for the siblings (range 42-73) and 46 years for the children 
(range 40-59). As shown in Table 1, there were no significant differences between relatives 
and controls regarding age, gender and geographical area. 
Colonoscopic findings among first-degree relatives and controls are shown in Table 2. 
Five cancers were observed in relatives (one TNM stage I, one stage II, one stage IV and two 
cancers with unknown stage) and 3 cancers in controls (one stage I and two stage III cancers). 
With these new observations in first-degree relatives, one family was found to meet 
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Amsterdam criteria (three affected members from two generations, of whom one was under 
50 at the diagnosis of colorectal cancer). Among subjects free of colorectal cancer, 33 
relatives and 47 controls presented at least one adenoma. Prevalence of adenomas was higher 
in men than in women in both relatives (24.0% versus 16.1%) and controls (17.3% versus 
14.9%). The prevalence of adenomas also increased with age in both relatives and controls. It 
was 17.7% in relatives under 60 and 22.7% in those over 60 whereas the corresponding 
figures were 11.0% and 22.4% in controls. 
Colorectal neoplasia was found in 38 out of 168 relatives (22.6%) and in 50 out of 307 
controls (16.3%). The prevalence of cancers was 3.0% in relatives and 1% in controls, and the 
prevalence of large adenomas was 5.4% and 3.3%, respectively.  
The risk associated with one first-degree relative affected by large adenomas depended 
on the severity of neoplasia (Table 2). For large adenomas and cancers considered together, 
the 0R was 2.27 (95% CI, 1.01-5.09). It was 1.21 for small adenoma (95% CI, 0.68-2.15). The 
overall risk of colorectal neoplasia was not significantly higher in relatives compared to 
controls, with an OR of 1.56 (95% CI, 0.96-2.53). One first-degree relative with large 
adenomas was not a significant risk factor for either high-risk adenomas (adenomas ≥10mm 
and/or villous component and/or severe dysplasia or carcinoma in situ) or multiple adenomas. 
These results did not change when relatives from a putative HNPCC family after detection of 
a cancer and their matched controls were excluded. 
Exclusion of first-degree relatives with a family history of colorectal cancer (n=32) 
and of their matched controls (n=59) only had a marginal influence on the overall risk of large 
adenomas and cancers considered together (OR, 2.09, 95% CI, 0.86-5.13; p=0.11), on the risk 
of small adenomas (OR, 1.23, 95% CI, 0.64-2.37, p=0.54), and on the overall risk of  
colorectal neoplasia (OR=1.57, 95% CI, 0.99-2.49, p=0.11). Similarly, the restriction of 
analysis to a case group composed of only one relative per family (n=96) and to matched 
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controls (n=174) one marginally affected risk estimates for both cancers/large adenomas (OR, 
2.62; 95% CI, 0.74-9.22; p=0.13), small adenomas (OR, 1.12; 95% CI, 0.54-2.31; p=0.76), 
and overall neoplasia (OR, 1.35; 95% CI, 0.71-2.58; p=0.36). 
As indicated in Table 3, certain characteristics of the index case affected the 
prevalence of colorectal neoplasia in relatives. The risk of finding large adenomas or cancers 
in first-degree relatives was higher when their index case was under 60 (OR=3.82; 95% CI, 
0.92-15.87; p=0.07), was male (OR=4.01; 95% CI, 1.45-11.09; p=0.01), presented a large 
adenoma in the distal colorectum (OR=3.14; 95% CI, 1.27-7.73; p=0.01), or had an advanced 
adenoma (OR, 2.31; 95%  CI, 0.88-6.04; p=0.09). For relatives of index cases with distal 
adenomas, the risk of large adenomas or cancers in the left colorectum was particularly high 
(OR, 3.22; 95% CI, 1.20-8.63; p=0.02). Moreover, relatives presented a higher risk of overall 
neolasia in the left colorectum (OR=2.27; 95% CI: 1.12-3.84, p=0.02) than in the right colon 
(OR, 0.68; 95% CI, 0.24-1.94; p=0.47). 
 
Discussion 
In this study, first-degree relatives of patients with large adenomas had an increased 
risk of both colorectal cancers and large adenomas. Moreover, the strength of the relationship 
varied according to certain characteristics of the index case. The risk was particularly high if 
the index case was under 60 at diagnosis of a large adenoma, male, or had a large adenoma in 
the left colorectum. It should be noted that having a first-degree relative with large adenoma 
had no significant influence on the overall risk of colorectal neoplasia because of the lack of 
effect on small adenomas 
This study had an original design and, to our knowledge, was the first to prospectively 
ask first-degree relatives of patients with large colorectal adenomas to undergo a 
colonoscopy, and to compare endoscopic findings to those observed in a control population. 
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This contrasts with previous studies which compared frequency of a family history of 
colorectal cancer among patients with newly diagnosed adenomas, with that among control 
12-
17
. In these studies, the choice of controls such as spouses or hospital controls is questionable 
and may lead to an underestimation of the association with family history. Furthermore, they 
do not allow for any assessment of the risk of adenoma in relatives. Indeed, first-degree 
relatives may had never undergone a colonoscopy and, even if this had been the case, the 
study subjects could have been unaware of the endoscopic findings in their relatives. 
Furthermore, these retrospective studies may be subject to recall biases, because patients with 
adenomas are more likely than control patients to remember a family history of colorectal 
cancer. Lastly, in most previous studies, no attempt had been made to validate a self-reported 
family history of colorectal cancer, by direct interview of relatives or by review of medical 
records. 
The present study also presented several limitations, suggesting however that our risk 
estimates were rather conservative. Because of recruitment procedures of relatives of patients 
with large adenomas, the ideal design could have been to offer a colonoscopy to first-degree 
relatives of polyp-free patients. Such a design was impossible for ethical and statutory 
considerations and we chose to include as controls, consecutive patients who had had a 
colonoscopy for minor symptoms and did not report any family history of colorectal cancer or 
adenoma. Our choice was guided by several considerations. First, first-degree relatives were 
generally asymptomatic, and it was preferable to have a control group as close as possible to 
this population. Second, the exclusion of patients with a family history of colorectal cancer 
had the advantage of discarding some patients with an unknown family history of colorectal 
adenomas, a feature probably common in the general population. Although this strategy could 
theoretically lead to an over-estimation of the differences in prevalence of neoplasia between 
cases and controls, it appeared to be the most appropriate because the family history of 
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colorectal cancer was the sole indication or one of the indications for colonoscopy in 92% of 
these patients. Despite these precautions, a history of large adenomas in first-degree relatives 
was probably unknown to certain controls, which in turn led to an under-estimation of the 
association with the risk of colorectal neoplasia. Another limitation was linked to the small 
proportion of first-degree relatives who agreed to participate in the study and underwent a 
colonoscopy. It is uncertain whether the participating first-degree relatives were truly 
representative of the 674 eligible first-degree relatives or of all 1763 living and deceased first-
degree relatives. However, we showed in previous research that the compliance of relatives 
with colonoscopy was only marginally influenced by the characteristics of both relatives and 
index cases 
9
, so that it is unlikely that major selection biases may have affected our study 
sample. The main determinants of compliance with colonoscopy for first-degree relatives 
were their young age and place of residence outside of Greater Paris area (both used as 
matching variables in the present analysis), whereas family history of colorectal cancer had no 
significant influence on participation rate. Usually, subjects who participate in screening 
programs are healthier than non participants. Thus, the observed frequency of colorectal 
neoplasia in relatives may be lower than the actual frequency, possibly resulting in an under-
estimation of the differences with controls. Another limitation was due to the lack of 
information about completeness of colonoscopy could be ascertained in 20% of relatives, 
generally examined outside study centres. Thus, if the colonoscopy was incomplete in some 
of these subjects, we cannot exclude attenuation in the relative risk of colorectal neoplasia. 
Lastly, because of the low participation rate of first-degree relatives, this is a relatively small-
sized study with a statistical power of only 75% to detect an OR of 2.5 associated with the 
risk of both cancers/large adenomas and a limited power to detect weaker associations 
between a family history of large adenomas and the risk of colorectal neoplasia.  
 14 
Despite these limitations, the findings of the present study showed striking similarities 
with those obtained in a previous French study, which used a comparable design for first-
degree relatives of patients with colorectal cancer 
7
. In this previous study as in the present 
one, no association was found with the risk of small adenomas (odds ratio of 1.2) whereas the 
risk of large adenomas was significantly increased by 2.5 in subjects with a family history of 
colorectal cancer. Eight of the nine studies included in a recent review also found an increased 
risk for first-degree relatives of colorectal cancer associated with adenoma, with a summary 
estimate of familial risk at 1.99 
5
. Only one of these studies examined the risk of colorectal 
cancer for first-degree relatives according to the size of adenomas in index cases 
13
. The 
comparison of several groups of adenoma patients and polyp-free controls revealed that the 
relative risk of colorectal cancer for first-degree relatives was higher in relatives of patients 
with large adenomas than in those with small adenomas (odds ratios of 2.1 and 1.2, 
respectively). These findings were partially confirmed by a recent study, which showed only a 
modest and non-significant increase in the risk of colorectal cancer in relatives of patients 
with small tubular adenomas (odds ratio of 1.26), and a significant increase in relatives of 
patients with advanced adenomas, i.e. adenomas larger than 10 mm and/or with villous 
component or high-grade dysplasia (odds ratio of 1.62) 
14
. Thus, despite some variations 
among studies in the magnitude of familial risk due to differences in study design and 
populations studied, there now appears to be strong evidence that first-degree relatives of 
patients with large adenomas are at high risk of developing colorectal neoplasia, whereas it is 
probably not the case for relatives of patients with small adenomas. This is consistent with 
epidemiological knowledge about adenomas. Adenomas are very common in the general 
population as indicated by autopsy studies 
16, 17
. In a French autopsy study, overall adenoma 
prevalence was around 28%, increasing from 16% in the under-64 age group to 33% in the 
65-74 age group and 46% in the over-74 age group (personal data). If all individuals with a 
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history of adenoma in their first-degree relatives were at high risk of colorectal neoplasia, the 
incidence of colorectal cancer in the general population would probably be higher than it is.  
There are some indications that the risk of colorectal neoplasia in relatives might 
depend on the characteristics of the affected family member. Indeed, this study showed an 
increased risk of neoplasia, especially of large adenomas and cancers, when the index case 
was male and younger than 60 years. A link between a younger age at adenoma diagnosis and 
familial risk of colorectal cancer has previously been reported in a number of studies 
10, 13, 15
 
but not in one study
 14
, possibly due to a narrower age range concerning adenoma patients. 
Furthermore, our study suggested that first-degree relatives of patients with a large distal 
adenoma could be more prone to develop colorectal neoplasia, especially distal large 
adenomas and cancers, than relatives of patients with proximal adenomas. Also in the study of 
Lynch et al. 
14
, the prevalence of family history of colorectal cancer was slightly higher in 
patients with distal adenomas than in patients with proximal adenomas. In addition, our 
previous work performed with a similar design among first-degree relatives of patients with 
colorectal cancer also revealed an influence of cancer location 
7
. In this latter study, relatives 
of patients with distal cancer were more likely to present high-risk adenomas than relatives of 
patients with proximal cancer. As in the present study, adenomas were more likely to be 
located on the left colon when the cancer site was the left colon. Thus, although no firm 
conclusions could be drawn from existing data, these may suggest some degree of 
resemblance in tumoral site among family members. This hypothesis needs to be more 
thoroughly investigated in future studies using appropriate design and sample size. 
Thus, there is now evidence that first-degree relatives of patients with large adenomas 
may need to be screened and monitored as carefully as relatives of patients with colorectal 
cancer. This may be especially true for relatives when the index case is younger than 60 years, 
male and had large adenomas in the left colorectum. However, screening recommendations 
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for relatives of patients with large adenomas raise some issues. At the individual level, 
colonoscopy would probably be the most appropriate screening method in these high- risk 
subjects. According to the most recent French recommendations, individuals with a family 
history of colon cancer or adenomas diagnosed in first-degree relatives under 60 should be 
advised to have screening colonoscopy either from the age of 45 years, or 5 years younger 
than the earliest diagnosis in their family 
18
. No well-defined specific recommendation was 
proposed for individuals with first-degree relatives older than 60 years diagnosed with 
colorectal cancer because of the small increase in risk. Likewise, American guidelines 
recommend colonoscopy at 40 years, or 10 years before the index case, for individuals with a 
strong family history of colorectal cancer or polyps 
19, 20
. However, from a public health point 
of view, there is no evidence that such screening strategies may be the most cost-effective if 
the acceptability of colonoscopy in first-degree relatives of patients with large adenomas is as 
low as in our study (around 20%). Furthermore, our previous analyses showed a strong intra-
familial correlation of colonoscopic screening acceptance, indicating that a large proportion of 
families would be completely excluded from screening (around 40%) 
9
. Appropriate strategies 
need to be developed to improve the acceptability of colonoscopy in affected families. Further 
studies are needed in order to compare the cost-effectiveness of alternative strategies to 
colonoscopy, such as faecal occult blood testing with sensitive tests and computed 
tomographic virtual colonoscopy. 
 17 
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Figure 1: Study population. 
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168 first-degree relatives  
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Table 1: Characteristics of first-degree relatives of patients with large adenomas (cases) 
and matched colonoscopic controls 
 
  Relatives  Matched controls 
  168  307 
Age (years) 
      
Mean (SD)  55.3 (9.9)  56.2 (10.0) 
<50 – n (%)  61 (36.3)  104 (33.9) 
50-59 – n (%)  41 (24.4)  69 (22.5) 
≥ 60 – n (%)  66 (39.3)  134 (43.6) 
       
Gender 
      
Women – n (%)  93 (55.4)  168 (54.7) 
Men – n (%)  75 (44.6)  139 (45.3) 
       
Geographical area 
      
Greater Paris area – n (%)  35 (20.8)  70 (22.8) 
North-East – n (%)  30 (17.9)  60 (19.5) 
South-West – n (%)  34 (20.2)  50 (16.3) 
South-East – n (%)  34 (20.2)  57 (18.6) 
Central France – n (%)  35 (20.8)  70 (22.8) 
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Table 2: Risk of colorectal neoplasia among first-degree relatives of patients with large 
adenomas 
  
Relatives 
N=168 
 
Matched 
controls 
N=307 
 
Adjusted odds Ratios* 
  n %  n %  OR 95% CI p 
No neoplasia  130 (77.4)  257 (83.7)  1   
Small adenomas  22 (13.3)  37 (12.0)  1.21 0.68-2.15 0.52 
Cancers or large adenomas  14 (8.4)  13 (4.2)  2.27 1.01-5.09 0.046 
cancers  5 (3.0)  3 (1.0)  3.90 0.89-17.01 0.07 
large adenomas  9 (5.4)  10 (3.3)  1.82 0.71-4.69 0.21 
All neoplasia †  38 (22.6)  50 (16.3)  1.56 0.96-2.53 0.075 
           
High-risk adenomas ‡  12 (7.2)  13 (4.2)  1.80 0.78-4.13 0.17 
Multiple adenomas  5 (3.0)  9 (2.9)  1.10 0.35.3.44 0.87 
           
Distal neoplasia ¶  28 (16.8)  35 (11.4)  1.66 0.95-2.91 0.076 
Proximal neoplasia ¶  10 (6.0)  19 (6.2)  1.14 0.51-2.58 0.75 
*: Adjustment for age, gender and geographical area of relatives and controls 
†: 2 missing sizes for adenomas 
‡: adenomas ≥10mm and/or villous component and/or severe dysplasia or carcinoma in 
situ. 
¶: 1 missing location 
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Table 3: Risk of colorectal neoplasia among first-degree relatives according to index case characteristics* 
 All neoplasia  Large adenomas and cancers 
Index case 
characteristics 
Relatives  
Matched 
controls 
 Adjusted odds ratio†  Relatives  
Matched 
controls 
 Adjusted odds ratio† 
 N    %  N    %  OR CI 95% p  N    %  N    %  OR CI 95% p 
Age  
               
Younger than 60  17/57 (29.8)  14/96 (14.6)  3.01 1.24-7.31 0.02  6/56 (10.7)  4/96 (4.2)  3.82 0.92-15.87 0.07 
60 or older 21/111 (18.9)  36/211 (17.1)  1.15 0.63-2.11 0.65  8/110 (7.3)  9/211 (4.3)  1.82 0.66-4.99 0.25 
                
Sex  
               
Female 14/68 (20.6)  21/124 (16.9)  1.34 0.62-2.88 0.46  2/66 (3.0)  6/124 (4.8)  0.65 0.12-3.40 0.61 
Male 24/100 (24.0)  29/183 (15.9)  1.77 0.93-3.34 0.08  12/100 (12.0)  7/183 (3.8)  4.01 1.45-11.09 0.01 
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Table 3 (continued) 
Adenoma location 
               
distal colorectum 31/138 (22.5)  40/259 (15.4)  1.65 0.96-2.83 0.07  13/136 (9.6)  9/259 (3.5)  3.14 1.27-7.73 0.01 
proximal colon 8/37 (21.6)  11/62 (17.7)  1.29 0.45-3.71 0.63  1/37 (2.7)  4/62 (6.5)  0.41 0.04-4.39 0.46 
Advanced 
adenomas ‡ 
               
yes 26/115 (22.6)  35/208 (16.8)  1.48 0.82-2.67 0.19  10/114 (13.2)  9/208 (4.3)  2.31 0.88-6.04 0.09 
no 12/53 (22.6)  15/99 (15.2)  1.74 0.72-4.18 0.22  7/52 (13.5)  11/99 (11.1)  2.19 0.48-10.03 0.31 
*: Logistic regression stratified by index case characteristics 
†: Adjustment for age, gender and geographical area of relatives and controls 
‡: Adenomas with villous component and/or severe dysplasia or carcinoma in situ 
 
 
